US Medical Director - XELJANZ and Inflectra - MD

Collegeville, Pennsylvania
May 14 2021
Position Type
Full Time
Organization Type
The US Medical Director Xeljanz and Inflectra will develop long-term relationships with a wide variety of key healthcare stakeholders and customers to include Medical Groups and key opinion leaders in order to demonstrate clinical and economic value of Pfizer's Xeljanz and Inflectra across therapeutic areas(Gastroenterology, Rheumatology, Biosimilars) and in the treatment of UC, RA, PsA, pcJIA, AS, etc... These activities are implemented to help inform HCPs and formulary decision-makers through medical presentations, pharmacoeconomic analyses, and outcomes evaluations along with MOS and FMD colleagues. Additional customer collaborations are built with the goal of aligning corporate medical priorities with the specific needs of the customer to advance the quality of patient care in areas of mutual interest, to identify provider and/or patient knowledge gaps, and areas for quality improvementinterventions. They will develop, in conjunction with Gastroenterology-Rheumatology-Biosimilars team members, an advanced perspective of the evolving clinical and healthcare landscape.

The Medical Director will utilize his/her understanding of clinical and patient-directed issues to help assist Pfizer and GMA on most strategic approach to supporting Xeljanz and Inflectra across therapeutic areas. The Medical Director will also provide Pfizer brand teams with customer and clinical insights to assist in informing Pfizer strategies on critical health issues and facilitate the development of customer-focused toolsand medical communications to support patient access to quality medicines

  • Participate in reviewing & approving promotional materials, ensuring fair balance
  • Cross functional efforts with constituents from Commercial, MOS, FMD, GH&V, RWD; partner with cross-functional colleagues to drive US strategic direction for the Brand
  • Ability to plan and lead successful advisory boards, congress-related symposia & congress planning
  • Ability contribute to Publication Planning, data generation activities and other medical/scientific activities related to informing HCPs on proper use of Xeljanz and Inflectra
  • Serve as a reliable, trusted source of accurate and scientific knowledge for Xeljanz and Inflectra data, disease state, product label and competitive data sets for clinical trials
  • Participate in developing and maintaining HCP engagement plans for HQ medical affairs

  • MD/DO or equivalent professional degrees with 7 + years of experience in eitherthe pharmaceutical industry, academic centers, clinical practice or a combination of these; Knowledge of pharmaceutical space in Inflammation and Immunology TAs
  • Experience in clinical development or Phase IV/IIR trial management a plus
  • Relationship builder within and outside of Pfizer
  • Excellent presentation and communication skills
  • Team oriented for success
  • Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.

  • U.S. Board certification and/or specialty training in gastroenterology or rheumatology preferred
  • Experience in Medical Affairs
  • Experience in Gastroenterology, Rheumatology or Biosimilars therapeutic areas


Ability to travel up to 20% post-pandemic

Other information:

Last Date to Apply for Job: May 24, 2021

Location: NY and Collegeville are highly preferred. Open to considering remote candidates.

NOT Eligible for Relocation Package

Eligible for Employee Referral Bonus


Sunshine Act

Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider's name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.

EEO & Employment Eligibility

Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.



Similar jobs

Similar jobs